The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site

KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 2011-08, Vol.187 (4), p.1816-1825
Hauptverfasser: Fu, Li, Hazes, Bart, Burshtyn, Deborah N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1825
container_issue 4
container_start_page 1816
container_title The Journal of immunology (1950)
container_volume 187
creator Fu, Li
Hazes, Bart
Burshtyn, Deborah N
description KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling.
doi_str_mv 10.4049/jimmunol.1002125
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_904488668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>904488668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</originalsourceid><addsrcrecordid>eNqFkL1PwzAQxS0EoqWwMyFvTCnnz9gjKtBGFCGhMkeOY0OqfJTYGfjvCWrLynTS3XtP934IXROYc-D6bls1zdB29ZwAUELFCZoSISCREuQpmo5LmpBUphN0EcIWACRQfo4mlKRcaimmaLn5dNhXfYg4-8Bl15iqxZ3Hz9kbe1gTbLs2GhsDflktsK1NCDjDJmKDgxtvpem_caiiu0Rn3tTBXR3mDL0_PW4Wq2T9uswW9-vEspTGRKaWKFVoxmzhuFe6pNILYbUf3-TaSlUokE4U3nCgvrRC-1IyQojwpmSOzdDtPnfXd1-DCzFvqmBdXZvWdUPINXCulJTqX6VSBFRKaToqYa-0fRdC73y-66tmbJYTyH8550fO-YHzaLk5hA9F48o_wxEs-wFAmnhP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881087227</pqid></control><display><type>article</type><title>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Fu, Li ; Hazes, Bart ; Burshtyn, Deborah N</creator><creatorcontrib>Fu, Li ; Hazes, Bart ; Burshtyn, Deborah N</creatorcontrib><description>KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.1002125</identifier><identifier>PMID: 21746965</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Antibodies, Monoclonal, Murine-Derived - immunology ; Antibodies, Monoclonal, Murine-Derived - pharmacology ; Antibodies, Neutralizing - immunology ; Antibodies, Neutralizing - pharmacology ; Binding Sites ; Cercopithecus aethiops ; COS Cells ; Histocompatibility Antigens Class I - genetics ; Histocompatibility Antigens Class I - immunology ; Histocompatibility Antigens Class I - metabolism ; Humans ; Protein Structure, Tertiary ; Receptors, KIR2DL1 - genetics ; Receptors, KIR2DL1 - immunology ; Receptors, KIR2DL1 - metabolism ; Receptors, KIR3DL1 - genetics ; Receptors, KIR3DL1 - immunology ; Receptors, KIR3DL1 - metabolism ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - immunology ; Recombinant Fusion Proteins - metabolism ; Signal Transduction - immunology</subject><ispartof>The Journal of immunology (1950), 2011-08, Vol.187 (4), p.1816-1825</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</citedby><cites>FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21746965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fu, Li</creatorcontrib><creatorcontrib>Hazes, Bart</creatorcontrib><creatorcontrib>Burshtyn, Deborah N</creatorcontrib><title>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling.</description><subject>Animals</subject><subject>Antibodies, Monoclonal, Murine-Derived - immunology</subject><subject>Antibodies, Monoclonal, Murine-Derived - pharmacology</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Neutralizing - pharmacology</subject><subject>Binding Sites</subject><subject>Cercopithecus aethiops</subject><subject>COS Cells</subject><subject>Histocompatibility Antigens Class I - genetics</subject><subject>Histocompatibility Antigens Class I - immunology</subject><subject>Histocompatibility Antigens Class I - metabolism</subject><subject>Humans</subject><subject>Protein Structure, Tertiary</subject><subject>Receptors, KIR2DL1 - genetics</subject><subject>Receptors, KIR2DL1 - immunology</subject><subject>Receptors, KIR2DL1 - metabolism</subject><subject>Receptors, KIR3DL1 - genetics</subject><subject>Receptors, KIR3DL1 - immunology</subject><subject>Receptors, KIR3DL1 - metabolism</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - immunology</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Signal Transduction - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkL1PwzAQxS0EoqWwMyFvTCnnz9gjKtBGFCGhMkeOY0OqfJTYGfjvCWrLynTS3XtP934IXROYc-D6bls1zdB29ZwAUELFCZoSISCREuQpmo5LmpBUphN0EcIWACRQfo4mlKRcaimmaLn5dNhXfYg4-8Bl15iqxZ3Hz9kbe1gTbLs2GhsDflktsK1NCDjDJmKDgxtvpem_caiiu0Rn3tTBXR3mDL0_PW4Wq2T9uswW9-vEspTGRKaWKFVoxmzhuFe6pNILYbUf3-TaSlUokE4U3nCgvrRC-1IyQojwpmSOzdDtPnfXd1-DCzFvqmBdXZvWdUPINXCulJTqX6VSBFRKaToqYa-0fRdC73y-66tmbJYTyH8550fO-YHzaLk5hA9F48o_wxEs-wFAmnhP</recordid><startdate>20110815</startdate><enddate>20110815</enddate><creator>Fu, Li</creator><creator>Hazes, Bart</creator><creator>Burshtyn, Deborah N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20110815</creationdate><title>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</title><author>Fu, Li ; Hazes, Bart ; Burshtyn, Deborah N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal, Murine-Derived - immunology</topic><topic>Antibodies, Monoclonal, Murine-Derived - pharmacology</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Neutralizing - pharmacology</topic><topic>Binding Sites</topic><topic>Cercopithecus aethiops</topic><topic>COS Cells</topic><topic>Histocompatibility Antigens Class I - genetics</topic><topic>Histocompatibility Antigens Class I - immunology</topic><topic>Histocompatibility Antigens Class I - metabolism</topic><topic>Humans</topic><topic>Protein Structure, Tertiary</topic><topic>Receptors, KIR2DL1 - genetics</topic><topic>Receptors, KIR2DL1 - immunology</topic><topic>Receptors, KIR2DL1 - metabolism</topic><topic>Receptors, KIR3DL1 - genetics</topic><topic>Receptors, KIR3DL1 - immunology</topic><topic>Receptors, KIR3DL1 - metabolism</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - immunology</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Signal Transduction - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fu, Li</creatorcontrib><creatorcontrib>Hazes, Bart</creatorcontrib><creatorcontrib>Burshtyn, Deborah N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fu, Li</au><au>Hazes, Bart</au><au>Burshtyn, Deborah N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2011-08-15</date><risdate>2011</risdate><volume>187</volume><issue>4</issue><spage>1816</spage><epage>1825</epage><pages>1816-1825</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling.</abstract><cop>United States</cop><pmid>21746965</pmid><doi>10.4049/jimmunol.1002125</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 2011-08, Vol.187 (4), p.1816-1825
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_904488668
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Animals
Antibodies, Monoclonal, Murine-Derived - immunology
Antibodies, Monoclonal, Murine-Derived - pharmacology
Antibodies, Neutralizing - immunology
Antibodies, Neutralizing - pharmacology
Binding Sites
Cercopithecus aethiops
COS Cells
Histocompatibility Antigens Class I - genetics
Histocompatibility Antigens Class I - immunology
Histocompatibility Antigens Class I - metabolism
Humans
Protein Structure, Tertiary
Receptors, KIR2DL1 - genetics
Receptors, KIR2DL1 - immunology
Receptors, KIR2DL1 - metabolism
Receptors, KIR3DL1 - genetics
Receptors, KIR3DL1 - immunology
Receptors, KIR3DL1 - metabolism
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - immunology
Recombinant Fusion Proteins - metabolism
Signal Transduction - immunology
title The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A30%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20first%20Ig%20domain%20of%20KIR3DL1%20contacts%20MHC%20class%20I%20at%20a%20secondary%20site&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Fu,%20Li&rft.date=2011-08-15&rft.volume=187&rft.issue=4&rft.spage=1816&rft.epage=1825&rft.pages=1816-1825&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.1002125&rft_dat=%3Cproquest_cross%3E904488668%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881087227&rft_id=info:pmid/21746965&rfr_iscdi=true